Catalyst Wire Dossier Catalyst Wire Dossier

IOFLUPANE I-123

ioflupane I-123 · Curium US LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IOFLUPANE I-123, covering 2022-03-30 to 2022-03-30. Get the full timeline:

Most recent: FDA Approved: IOFLUPANE I 123 — Original Application (Curium US LLC)

See pricing